The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ADMA BIOLOGICS INC | COM | 000899104 | 10,966 | 4,588,352 | SH | SOLE | 4,588,352 | 0 | 0 | ||
| AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 128,625 | 9,450,763 | SH | SOLE | 9,450,763 | 0 | 0 | ||
| ANI PHARMACEUTICALS INC | COM | 00182C103 | 6,435 | 142,943 | SH | SOLE | 142,943 | 0 | 0 | ||
| AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 68 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | ||
| CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 18,052 | 9,402,317 | SH | SOLE | 9,402,317 | 0 | 0 | ||
| CORCEPT THERAPEUTICS INC | COM | 218352102 | 82,992 | 6,211,964 | SH | SOLE | 6,211,964 | 0 | 0 | ||
| EXELIXIS INC | COM | 30161Q104 | 130,709 | 6,645,113 | SH | SOLE | 6,645,113 | 0 | 0 | ||
| KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 45,070 | 4,810,078 | SH | SOLE | 4,810,078 | 0 | 0 | ||
| LUMINEX CORP DEL | COM | 55027E102 | 55,528 | 2,402,787 | SH | SOLE | 2,402,787 | 0 | 0 | ||
| MYRIAD GENETICS INC | COM | 62855J104 | 68,905 | 2,370,296 | SH | SOLE | 2,370,296 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 32,970 | 2,579,784 | SH | SOLE | 2,579,784 | 0 | 0 | ||
| PACIFIC BIOSCIENCES CALIF IN | COM | 69404D108 | 18,168 | 2,455,114 | SH | SOLE | 2,455,114 | 0 | 0 | ||
| PACIRA PHARMACEUTICALS INC | COM | 695127100 | 157,115 | 3,652,134 | SH | SOLE | 3,652,134 | 0 | 0 | ||
| RADIUS HEALTH INC | NOTE 3.000% 9/0 | 750469AA6 | 6,900 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
| RETROPHIN INC | COM | 761299106 | 91,247 | 4,032,123 | SH | SOLE | 4,032,123 | 0 | 0 | ||
| SAVARA INC | COM | 805111101 | 23,419 | 3,093,690 | SH | SOLE | 3,093,690 | 0 | 0 | ||
| SESEN BIO INC | COM | 817763105 | 10,683 | 7,523,296 | SH | SOLE | 7,523,296 | 0 | 0 | ||
| SPECTRUM PHARMACEUTICALS INC | COM | 84763A108 | 25,979 | 2,969,027 | SH | SOLE | 2,969,027 | 0 | 0 | ||
| STEMLINE THERAPEUTICS INC | COM | 85858C107 | 10,980 | 1,155,793 | SH | SOLE | 1,155,793 | 0 | 0 | ||
| UNIQURE NV | SHS | N90064101 | 54,649 | 1,896,226 | SH | SOLE | 1,896,226 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 119,855 | 1,100,597 | SH | SOLE | 1,100,597 | 0 | 0 | ||
| UROGEN PHARMA LTD | COM | M96088105 | 65,254 | 1,515,422 | SH | SOLE | 1,515,422 | 0 | 0 | ||
| VANDA PHARMACEUTICALS INC | COM | 921659108 | 121,733 | 4,658,759 | SH | SOLE | 4,658,759 | 0 | 0 | ||
| VERICEL CORP | COM | 92346J108 | 73,395 | 4,218,092 | SH | SOLE | 4,218,092 | 0 | 0 | ||